Roser Mir

YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression

Roser Mir, Elisabetta Stanzani, Fina Martínez‐Soler et al. · Gynecologic Oncology · 2013 · 41 citations

Medicine, Oncology, Pharmacology +15

Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in <i>TP53</i> wild‐type ovarian cancer cells

Roser Mir, Avelina Tortosa, Fina Martínez‐Soler et al. · International Journal of Cancer · 2012 · 40 citations

Medicine, Oncology, Pharmacology +17

Liposomes Co-Encapsulating Cisplatin/Mifepristone Improve the Effect on Cervical Cancer: In Vitro and In Vivo Assessment

Fabricio Ledezma-Gallegos, Rafael Jurado, Roser Mir et al. · Pharmaceutics · 2020 · 37 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo study

Mariana Segovia‐Mendoza, Rafael Jurado, Roser Mir et al. · BMC Cancer · 2015 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients

Pierre Chelle, Cindy H. T. Yeung, Santiago Bonanad et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2019 · 19 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15